Summary
Becton, Dickinson and Company (BDX) disclosed on June 7, 2006, that its subsidiary UltiMed, Inc. has been sued in the United States District Court. The lawsuit, filed on June 5, 2006, alleges that BDX engaged in anticompetitive practices by entering into exclusionary contracts that allegedly prevented UltiMed, Inc. from accessing the market for home-use insulin syringes. The plaintiff is seeking unspecified monetary damages and injunctive relief. BDX management has stated that they believe they have strong defenses against these claims and intend to vigorously contest the lawsuit. Investors should monitor this litigation, as a negative outcome could potentially result in financial penalties or operational restrictions for the company. However, the amount of damages sought is currently undisclosed, and the company's assertion of meritorious defenses suggests a degree of confidence in its position.
Key Highlights
- 1Becton, Dickinson and Company (BDX) is facing a lawsuit filed by UltiMed, Inc.
- 2The lawsuit, filed on June 5, 2006, alleges antitrust violations related to market exclusion for home-use insulin syringes.
- 3Plaintiff UltiMed, Inc. claims BDX entered into anticompetitive contracts.
- 4The plaintiff is seeking unspecified money damages and injunctive relief.
- 5BDX believes it has meritorious defenses and intends to defend the lawsuit vigorously.